Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA
- 14 March 1985
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 35 (3) , 359-366
- https://doi.org/10.1002/ijc.2910350312
Abstract
The Epstein-Barr virus-determined nuclear antigen (EBNA) is the only known virally-determined component that is regularly associated with EBV-transformed cells. A main component of EBNA, herein designated EBNA-I, has been conclusively localized to the BamHI K fragment of the viral genome. EBNA-I is present in all EBV-carrying cell lines so far studied. Our current study deals with a 2nd component. The EBNA reaction detected by anticomplement immunofluorescence (ACIF) in Burkitt lymphoma lines Daudi, jijoye, and P3HR-I could be completely removed by preabsorption of sera with any 1 of these 3 lines, when tested against any other of them. The same absorbed sera still gave a brilliant nuclear staining against other EBV-carrying lines, e.g. Raji or B95-8. The 3 lines in the 1st category carry EBV genomes that have deletions in the BamHI WYH region of the EBV genome. This region is intact in the 2nd group of lines. This result is interpreted as showing the existence of 2 different ACIF-stainable EBV-determined nuclear antigens, 1 of which is associated with the BamHI WYH region. This antigen was designated as EBNA-2. The 2 different EBNAs are different with regard to their association with metaphase chromosomes. In lines positive for both EBNA subtypes, metaphase chromosomes gave brilliant EBNA-I staining, but could not be stained for EBNA-2, indicating differences in chromatin association of the 2 EBNAs. An 86 kd polypeptide was identified by immunoblotting of DNA-binding proteins from EBV-transformed lymphoid cell lines. EBV-specificity of the polypeptide was demonstrated by the presence of antibodies against this polypeptide in antisera from a population of EBV-seropositive donors, but not from seronegative donors, by the presence of the polypeptide itself in EBV-carrying but not in EBV-negative cell lines and by the appearance of antibodies against this polypeptide during the course of infectious mononucleosis (IM). The polypeptide was absent from the EBV-carrying P3HR-I, Daudi and Jijoye cell lines, which suggested that it may be encoded by the BamHI WYH region that is deleted from the viral substrains carried by these lines.This publication has 34 references indexed in Scilit:
- Distinction between burkitt lymphoma subgroups by monoclonal antibodies: Relationships between antigen expression and type of chromosomal translocationInternational Journal of Cancer, 1984
- Molecular Size Variation of EBNA is Determined by the EB Viral GenomeIntervirology, 1983
- Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probeCell, 1982
- Epstein-Barr virus RNA in Burkitt tumor tissueCell, 1979
- Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBVInternational Journal of Cancer, 1978
- Detection of a nuclear, EBNA‐type antigen in apparently EBNA‐negative Herpesvirus papio (HVP)‐transformed lymphoid lines by the acid‐fixed nuclear binding techniqueInternational Journal of Cancer, 1977
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virusInternational Journal of Cancer, 1968
- Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt CellsScience, 1967